Is AngioDynamics a Winner in the Medical Device Industry? By StockNews
[ad_1]

The shares of the leading manufacturer of minimally-invasive medical devices AngioDynamics (NASDAQ) stocks have surged following solid quarterly revenue and investment in the Med Tech platform. But, with the uncertain outlook for growth and increased competition in medical devices, will the stock rally? Let’s find out.Industry-leading medical devices provider AngioDynamics, Inc. (ANGO) offers innovative diagnostic and surgical devices to treat cancer and peripheral vascular disease in the United States and internationally. Its shares have gained 17.5% in the last five days, and 79.5% this year, thanks to a strong revenue performance. This is due to a 68% increase in Med Tech net sales over the previous quarter. Investor attention has also been drawn to the limited release in market of AlphaVac’s mechanical thrombectomy machine.
While the minimally invasive medical devices provider’s Auryon and NanoKnife businesses continue to witness strong demand, finding more growth may be challenging for the company, given the COVID-19 related headwinds and increased competition in the medical devices market.
Here’s what could influence ANGO’s performance in the coming months:
Fusion MediaFusion Media and anyone associated with it will not assume any responsibility for losses or damages arising from the use of this information. This includes data including charts and buy/sell signal signals. Trading the financial markets is one of most risky investment options. Please make sure you are fully aware about the costs and risks involved.
[ad_2]